Literature DB >> 28129932

Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8+ T cell activation.

Hong-Di Ma1, Wen-Tao Ma1, Qing-Zhi Liu1, Zhi-Bin Zhao1, Mu-Zi-Ying Liu1, Koichi Tsuneyama2, Jin-Ming Gao3, William M Ridgway4, Aftab A Ansari5, M Eric Gershwin6, Yun-Yun Fei7, Zhe-Xiong Lian8.   

Abstract

CXC Chemokine Receptor 3 (CXCR3) is functionally pleiotropic and not only plays an important role in chemotaxis, but also participates in T cell differentiation and may play a critical role in inducing and maintaining immune tolerance. These observations are particularly critical for autoimmune cholangitis in which CXCR3 positive T cells are found around the portal areas of both humans and mouse models of primary biliary cholangitis (PBC). Herein, we investigated the role of CXCR3 in the pathogenesis of autoimmune cholangitis. We have taken advantage of a unique CXCR3 knockout dnTGFβRII mouse to focus on the role of CXCR3, both by direct observation of its influence on the natural course of disease, as well as through adoptive transfer studies into Rag-/- mice. We report herein that not only do CXCR3 deficient mice develop an exacerbation of autoimmune cholangitis associated with an expanded effector memory T cell number, but also selective adoptive transfer of CXCR3 deficient CD8+ T cells induces autoimmune cholangitis. In addition, gene microarray analysis of CXCR3 deficient CD8+ T cells reveal an intense pro-inflammatory profile. Our data suggests that the altered gene profiles induced by CXCR3 deficiency promotes autoimmune cholangitis through pathogenic CD8+ T cells. These data have significance for human PBC and other autoimmune liver diseases in which therapeutic intervention might be directed to chemokines and/or their receptors.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD8+T cell gene expression profile; Interferon-gamma induced chemokines; KLRG1; Primary biliary cholangitis; T-bet

Mesh:

Substances:

Year:  2017        PMID: 28129932      PMCID: PMC5357510          DOI: 10.1016/j.jaut.2016.12.012

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  44 in total

1.  Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis.

Authors:  Hiroto Kita; Shuji Matsumura; Xiao-Song He; Aftab A Ansari; Zhe-Xiong Lian; Judy Van de Water; Ross L Coppel; Marshall M Kaplan; M Eric Gershwin
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.

Authors:  Guo-Xiang Yang; Zhe-Xiong Lian; Ya-Hui Chuang; Yuki Moritoki; Ruth Y Lan; Kanji Wakabayashi; Aftab A Ansari; Richard A Flavell; William M Ridgway; Ross L Coppel; Koichi Tsuneyama; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

3.  Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T-cell generation.

Authors:  Joyce K Hu; Takashi Kagari; Jonathan M Clingan; Mehrdad Matloubian
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

4.  Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis.

Authors:  Mitsuko Furuya; Tomona Yoneyama; Etsuko Miyagi; Reiko Tanaka; Kiyotaka Nagahama; Yohei Miyagi; Yoji Nagashima; Fumiki Hirahara; Yoshiaki Inayama; Ichiro Aoki
Journal:  Gynecol Oncol       Date:  2011-09       Impact factor: 5.482

5.  Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis.

Authors:  Yin-Hu Wang; Wei Yang; Jing-Bo Yang; Yan-Jie Jia; Wei Tang; M Eric Gershwin; William M Ridgway; Zhe-Xiong Lian
Journal:  J Autoimmun       Date:  2015-02-17       Impact factor: 7.094

6.  Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.

Authors:  Sabine Oertelt; Zhe-Xiong Lian; Chun-Mei Cheng; Ya-Hui Chuang; Kerstien A Padgett; Xiao-Song He; William M Ridgway; Aftab A Ansari; Ross L Coppel; Ming O Li; Richard A Flavell; Mitchell Kronenberg; Ian R Mackay; M Eric Gershwin
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

7.  Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.

Authors:  Wenting Huang; Kritika Kachapati; David Adams; Yuehong Wu; Patrick S C Leung; Guo-Xiang Yang; Weici Zhang; Aftab A Ansari; Richard A Flavell; M Eric Gershwin; William M Ridgway
Journal:  J Autoimmun       Date:  2014-02-18       Impact factor: 7.094

Review 8.  The causes of primary biliary cirrhosis: Convenient and inconvenient truths.

Authors:  M Eric Gershwin; Ian R Mackay
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

9.  CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration.

Authors:  Manoj Thapa; Daniel J J Carr
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

10.  An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.

Authors:  Laura Lasagni; Michela Francalanci; Francesco Annunziato; Elena Lazzeri; Stefano Giannini; Lorenzo Cosmi; Costanza Sagrinati; Benedetta Mazzinghi; Claudio Orlando; Enrico Maggi; Fabio Marra; Sergio Romagnani; Mario Serio; Paola Romagnani
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  10 in total

Review 1.  Autoimmunity in 2017.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 2.  Primary biliary cholangitis: pathogenesis and therapeutic opportunities.

Authors:  Aliya F Gulamhusein; Gideon M Hirschfield
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-09       Impact factor: 46.802

3.  Liver-resident NK cells suppress autoimmune cholangitis and limit the proliferation of CD4+ T cells.

Authors:  Zhi-Bin Zhao; Fang-Ting Lu; Hong-Di Ma; Yin-Hu Wang; Wei Yang; Jie Long; Qi Miao; Weici Zhang; Zhigang Tian; William M Ridgway; Jie Cao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Cell Mol Immunol       Date:  2019-03-15       Impact factor: 11.530

4.  A Mouse Model of Autoimmune Cholangitis via Syngeneic Bile Duct Protein Immunization.

Authors:  Wen-Tao Ma; Qing-Zhi Liu; Jing-Bo Yang; Yan-Qing Yang; Zhi-Bin Zhao; Hong-Di Ma; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

Review 5.  Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development.

Authors:  Aleksandar Arsenijevic; Bojana Stojanovic; Jelena Milovanovic; Dragana Arsenijevic; Nebojsa Arsenijevic; Marija Milovanovic
Journal:  Int J Mol Sci       Date:  2020-07-19       Impact factor: 5.923

6.  Single-Cell Characterization of Hepatic CD8+ T Cells in a Murine Model of Primary Biliary Cholangitis.

Authors:  Yichen Han; Zhen-Hua Bian; Si-Yu Yang; Cheng-Bo Wang; Liang Li; Yan-Qing Yang; Aftab A Ansari; M Eric Gershwin; Xiaofeng Zeng; Zhe-Xiong Lian; Zhi-Bin Zhao
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

7.  Echinococcus granulosus: The establishment of the metacestode in the liver is associated with control of the CD4+ T-cell-mediated immune response in patients with cystic echinococcosis and a mouse model.

Authors:  Xinling Hou; Yang Shi; Xuejiao Kang; Zibigu Rousu; Dewei Li; Maolin Wang; Abidan Ainiwaer; Xuran Zheng; MingKun Wang; Bahejiang Jiensihan; Liang Li; Jing Li; Hui Wang; Chuanshan Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-08-15       Impact factor: 6.073

8.  The CXC Chemokine Receptor 3 Inhibits Autoimmune Cholangitis via CD8+ T Cells but Promotes Colitis via CD4+ T Cells.

Authors:  Qing-Zhi Liu; Wen-Tao Ma; Jing-Bo Yang; Zhi-Bin Zhao; Kai Yan; Yuan Yao; Liang Li; Qi Miao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

9.  Therapeutic and immunological interventions in primary biliary cholangitis: from mouse models to humans.

Authors:  Atsushi Tanaka; Patrick S C Leung; Howard A Young; M Eric Gershwin
Journal:  Arch Med Sci       Date:  2017-10-24       Impact factor: 3.318

10.  Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice.

Authors:  Yuki Moritoki; Koichi Tsuneyama; Yuka Nakamura; Kentaro Kikuchi; Akira Shiota; Yoshiyuki Ohsugi; Zhe-Xiong Lian; Weici Zhang; Guo-Xiang Yang; Shigeharu Ueki; Masahide Takeda; Ayumi Omokawa; Tomoo Saga; Akiko Saga; Daisuke Watanabe; Masahito Miura; Yoshiyuki Ueno; Patrick S C Leung; Atsushi Tanaka; M Eric Gershwin; Makoto Hirokawa
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.